These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 29788053)

  • 1. Reversing Ongoing Chronic Intestinal Inflammation and Fibrosis by Sustained Block of IL-12 and IL-23 Using a Vaccine in Mice.
    Guan Q; Weiss CR; Wang S; Qing G; Yang X; Warrington RJ; Bernstein CN; Peng Z
    Inflamm Bowel Dis; 2018 Aug; 24(9):1941-1952. PubMed ID: 29788053
    [No Abstract]   [Full Text] [Related]  

  • 2. Targeting IL-12/IL-23 by employing a p40 peptide-based vaccine ameliorates TNBS-induced acute and chronic murine colitis.
    Guan Q; Ma Y; Hillman CL; Qing G; Ma AG; Weiss CR; Zhou G; Bai A; Warrington RJ; Bernstein CN; Peng Z
    Mol Med; 2011; 17(7-8):646-56. PubMed ID: 21424108
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of recombinant vaccines against IL-12/IL-23 p40 and in vivo evaluation of their effects in the downregulation of intestinal inflammation in murine colitis.
    Guan Q; Ma Y; Hillman CL; Ma A; Zhou G; Qing G; Peng Z
    Vaccine; 2009 Nov; 27(50):7096-104. PubMed ID: 19786142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Employing an IL-23 p19 vaccine to block IL-23 ameliorates chronic murine colitis.
    Guan Q; Burtnick HA; Qing G; Weiss CR; Ma AG; Ma Y; Warrington RJ; Peng Z
    Immunotherapy; 2013 Dec; 5(12):1313-22. PubMed ID: 24283842
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Delivery of IL-12p40 ameliorates DSS-induced colitis by suppressing IL-17A expression and inflammation in the intestinal mucosa.
    Kim DJ; Kim KS; Song MY; Seo SH; Kim SJ; Yang BG; Jang MH; Sung YC
    Clin Immunol; 2012 Sep; 144(3):190-9. PubMed ID: 22836084
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An interleukin 12 p40-IgG2b fusion protein abrogates T cell mediated inflammation: anti-inflammatory activity in Crohn's disease and experimental colitis in vivo.
    Stallmach A; Marth T; Weiss B; Wittig BM; Hombach A; Schmidt C; Neurath M; Zeitz M; Zeuzem S; Abken H
    Gut; 2004 Mar; 53(3):339-45. PubMed ID: 14960512
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 4SC-101, a novel immunosuppressive drug, inhibits IL-17 and attenuates colitis in two murine models of inflammatory bowel disease.
    Fitzpatrick LR; Deml L; Hofmann C; Small JS; Groeppel M; Hamm S; Lemstra S; Leban J; Ammendola A
    Inflamm Bowel Dis; 2010 Oct; 16(10):1763-77. PubMed ID: 20310011
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intervention of Isomaltodextrin Mitigates Intestinal Inflammation in a Dextran Sodium Sulfate-Induced Mouse Model of Colitis via Inhibition of Toll-like Receptor-4.
    Majumder K; Fukuda T; Zhang H; Sakurai T; Taniguchi Y; Watanabe H; Mitsuzumi H; Matsui T; Mine Y
    J Agric Food Chem; 2017 Feb; 65(4):810-817. PubMed ID: 28102669
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IL-17/IFN-γ interactions regulate intestinal inflammation in TNBS-induced acute colitis.
    Jin Y; Lin Y; Lin L; Zheng C
    J Interferon Cytokine Res; 2012 Nov; 32(11):548-56. PubMed ID: 23030668
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validation of murine dextran sulfate sodium-induced colitis using four therapeutic agents for human inflammatory bowel disease.
    Melgar S; Karlsson L; Rehnström E; Karlsson A; Utkovic H; Jansson L; Michaëlsson E
    Int Immunopharmacol; 2008 Jun; 8(6):836-44. PubMed ID: 18442787
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Calcitriol analog ZK191784 ameliorates acute and chronic dextran sodium sulfate-induced colitis by modulation of intestinal dendritic cell numbers and phenotype.
    Strauch UG; Obermeier F; Grunwald N; Dunger N; Rath HC; Schölmerich J; Steinmeyer A; Zügel U; Herfarth HH
    World J Gastroenterol; 2007 Dec; 13(48):6529-37. PubMed ID: 18161923
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Berberine ameliorates chronic relapsing dextran sulfate sodium-induced colitis in C57BL/6 mice by suppressing Th17 responses.
    Li YH; Xiao HT; Hu DD; Fatima S; Lin CY; Mu HX; Lee NP; Bian ZX
    Pharmacol Res; 2016 Aug; 110():227-239. PubMed ID: 26969793
    [TBL] [Abstract][Full Text] [Related]  

  • 13. R-spondin1, a novel intestinotrophic mitogen, ameliorates experimental colitis in mice.
    Zhao J; de Vera J; Narushima S; Beck EX; Palencia S; Shinkawa P; Kim KA; Liu Y; Levy MD; Berg DJ; Abo A; Funk WD
    Gastroenterology; 2007 Apr; 132(4):1331-43. PubMed ID: 17408649
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel anti-inflammatory agent 3-[(dodecylthiocarbonyl)-methyl]-glutarimide ameliorates murine models of inflammatory bowel disease.
    Ichikawa N; Yamashita K; Funakoshi T; Ichihara S; Fukai M; Ogura M; Kobayashi N; Zaitsu M; Yoshida T; Shibasaki S; Koshizuka Y; Tsunetoshi Y; Sato M; Einama T; Ozaki M; Umezawa K; Suzuki T; Todo S
    Inflamm Res; 2016 Mar; 65(3):245-60. PubMed ID: 26683259
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of experimental mouse models of inflammatory bowel disease.
    Oh SY; Cho KA; Kang JL; Kim KH; Woo SY
    Int J Mol Med; 2014 Feb; 33(2):333-40. PubMed ID: 24285285
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel NF-κB inhibitor, dehydroxymethylepoxyquinomicin, ameliorates inflammatory colonic injury in mice.
    Funakoshi T; Yamashita K; Ichikawa N; Fukai M; Suzuki T; Goto R; Oura T; Kobayashi N; Katsurada T; Ichihara S; Ozaki M; Umezawa K; Todo S
    J Crohns Colitis; 2012 Mar; 6(2):215-25. PubMed ID: 22325176
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Resveratrol Ameliorates Intestinal Barrier Defects and Inflammation in Colitic Mice and Intestinal Cells.
    Mayangsari Y; Suzuki T
    J Agric Food Chem; 2018 Dec; 66(48):12666-12674. PubMed ID: 30426751
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting TGF-beta1 by employing a vaccine ameliorates fibrosis in a mouse model of chronic colitis.
    Ma Y; Guan Q; Bai A; Weiss CR; Hillman CL; Ma A; Zhou G; Qing G; Peng Z
    Inflamm Bowel Dis; 2010 Jun; 16(6):1040-50. PubMed ID: 19924805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The bile acid receptor FXR is a modulator of intestinal innate immunity.
    Vavassori P; Mencarelli A; Renga B; Distrutti E; Fiorucci S
    J Immunol; 2009 Nov; 183(10):6251-61. PubMed ID: 19864602
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Curcumin ameliorates dextran sulfate sodium-induced colitis in mice via regulation of autophagy and intestinal immunity.
    Yue W; Liu Y; Li X; Lv L; Huang J; Liu J
    Turk J Gastroenterol; 2019 Mar; 30(3):290-298. PubMed ID: 30923033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.